Overview Dividends

(AME) Ametek - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0311001004

Instruments,Sensors,Power,Connectors,Motors,Components

EPS (Earnings per Share)

EPS (Earnings per Share) of AME over the last years for every Quarter: "2020-09": 1.01, "2020-12": 1.08, "2021-03": 1.07, "2021-06": 1.15, "2021-09": 1.26, "2021-12": 1.37, "2022-03": 1.33, "2022-06": 1.38, "2022-09": 1.45, "2022-12": 1.52, "2023-03": 1.49, "2023-06": 1.57, "2023-09": 1.64, "2023-12": 1.68, "2024-03": 1.64, "2024-06": 1.66, "2024-09": 1.47, "2024-12": 1.87, "2025-03": 1.52, "2025-06": 1.78, "2025-09": 1.89,
EPS Growth (3y CAGR): 8.24%
EPS Trend (3y Corr): 59.9%
Last SUE: 4.00σ
Qual. Beats: 17

Revenue

Revenue of AME over the last years for every Quarter: 2020-09: 1126.942, 2020-12: 1198.947, 2021-03: 1215.742, 2021-06: 1386.346, 2021-09: 1440.681, 2021-12: 1503.745, 2022-03: 1458.525, 2022-06: 1514.552, 2022-09: 1551.786, 2022-12: 1625.667, 2023-03: 1597.117, 2023-06: 1646.111, 2023-09: 1622.837, 2023-12: 1730.885, 2024-03: 1736.18, 2024-06: 1734.834, 2024-09: 1708.564, 2024-12: 1761.602, 2025-03: 1731.971, 2025-06: 1778.056, 2025-09: 1892.641,
Revenue Growth (3y CAGR): 5.68%
Revenue Trend (3y Corr): 89.3%
Last SUE: 2.21σ
Qual. Beats: 2
Risk via 10d forecast
Volatility 20.4%
Value at Risk 5%th 30.3%
Relative Tail Risk -9.56%
Reward TTM
Sharpe Ratio -0.12
Alpha -12.17
Character TTM
Hurst Exponent 0.295
Beta 0.790
Beta Downside 0.866
Drawdowns 3y
Max DD 23.04%
Mean DD 5.56%
Median DD 5.36%

Description: AME Ametek September 29, 2025

AMETEK (NYSE:AME) operates two primary divisions: Electronic Instruments Group (EIG) and Electromechanical Group (EMG). The EIG segment supplies advanced instrumentation across process, aerospace, power, and industrial markets, covering everything from oil-and-gas analytical tools to aerospace sensor suites. The EMG segment focuses on engineered medical components, precision motion-control products, specialty metals, and thermal-management systems, and also runs a network of aviation MRO facilities.

In fiscal 2023 the company generated approximately $7.4 billion in revenue, with the EIG division contributing roughly 55 % and EMG the remaining 45 %. Operating margins hovered near 15 %, reflecting strong pricing power in niche aerospace and medical-device markets. Recent quarterly results (Q3-2024) showed earnings per share of $2.10, beating consensus estimates by 8 %.

Key drivers for AMETEK include sustained defense-spending growth (U.S. defense budget up ~5 % YoY), expanding semiconductor capital-expenditure cycles that boost demand for high-precision test equipment, and aging-population trends that underpin medical-device consumption. Conversely, a slowdown in oil-and-gas capital spending could pressure the process-instrument sub-segment. For a deeper quantitative view, you may want to explore ValueRay’s detailed earnings model for AME.

AME Stock Overview

Market Cap in USD 44,694m
Sub-Industry Electrical Components & Equipment
IPO / Inception 1984-07-19
Return 12m vs S&P 500 -12.9%
Analyst Rating 4.11 of 5

AME Dividends

Metric Value
Dividend Yield 0.80%
Yield on Cost 5y 1.34%
Yield CAGR 5y 11.68%
Payout Consistency 94.3%
Payout Ratio 17.6%

AME Growth Ratios

Metric Value
CAGR 3y 11.10%
CAGR/Max DD Calmar Ratio 0.48
CAGR/Mean DD Pain Ratio 2.00
Current Volume 1619.7k
Average Volume 1417.4k

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (1.47b TTM) > 0 and > 6% of Revenue (6% = 429.9m TTM)
FCFTA 0.10 (>2.0%) and ΔFCFTA -1.26pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 5.75% (prev 11.10%; Δ -5.35pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.11 (>3.0%) and CFO 1.77b > Net Income 1.47b (YES >=105%, WARN >=100%)
Net Debt (2.31b) to EBITDA (2.16b) ratio: 1.07 <= 3.0 (WARN <= 3.5)
Current Ratio 1.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (231.7m) change vs 12m ago -0.24% (target <= -2.0% for YES)
Gross Margin 36.18% (prev 35.41%; Δ 0.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 46.30% (prev 46.79%; Δ -0.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 23.01 (EBITDA TTM 2.16b / Interest Expense TTM 80.4m) >= 6 (WARN >= 3)

Altman Z'' 5.51

(A) 0.03 = (Total Current Assets 3.06b - Total Current Liabilities 2.65b) / Total Assets 16.18b
(B) 0.74 = Retained Earnings (Balance) 11.92b / Total Assets 16.18b
(C) 0.12 = EBIT TTM 1.85b / Avg Total Assets 15.47b
(D) 2.03 = Book Value of Equity 11.49b / Total Liabilities 5.66b
Total Rating: 5.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 79.10

1. Piotroski 6.50pt = 1.50
2. FCF Yield 3.49% = 1.75
3. FCF Margin 22.93% = 5.73
4. Debt/Equity 0.26 = 2.47
5. Debt/Ebitda 1.07 = 1.67
6. ROIC - WACC (= 4.07)% = 5.09
7. RoE 14.49% = 1.21
8. Rev. Trend 89.26% = 6.69
9. EPS Trend 59.92% = 3.00

What is the price of AME shares?

As of November 19, 2025, the stock is trading at USD 189.90 with a total of 1,619,704 shares traded.
Over the past week, the price has changed by -3.92%, over one month by +1.34%, over three months by +4.16% and over the past year by -1.08%.

Is AME a buy, sell or hold?

Ametek has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy AME.
  • Strong Buy: 10
  • Buy: 2
  • Hold: 5
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the AME price?

Issuer Target Up/Down from current
Wallstreet Target Price 219.9 15.8%
Analysts Target Price 219.9 15.8%
ValueRay Target Price 206.6 8.8%

AME Fundamental Data Overview November 17, 2025

Market Cap USD = 44.69b (44.69b USD * 1.0 USD.USD)
P/E Trailing = 30.4984
P/E Forward = 26.1097
P/S = 6.2385
P/B = 4.2284
P/EG = 2.8834
Beta = 1.045
Revenue TTM = 7.16b USD
EBIT TTM = 1.85b USD
EBITDA TTM = 2.16b USD
Long Term Debt = 1.43b USD (from longTermDebt, last quarter)
Short Term Debt = 1.10b USD (from shortTermDebt, last quarter)
Debt = 2.75b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.31b USD (from netDebt column, last quarter)
Enterprise Value = 47.00b USD (44.69b + Debt 2.75b - CCE 439.2m)
Interest Coverage Ratio = 23.01 (Ebit TTM 1.85b / Interest Expense TTM 80.4m)
FCF Yield = 3.49% (FCF TTM 1.64b / Enterprise Value 47.00b)
FCF Margin = 22.93% (FCF TTM 1.64b / Revenue TTM 7.16b)
Net Margin = 20.50% (Net Income TTM 1.47b / Revenue TTM 7.16b)
Gross Margin = 36.18% ((Revenue TTM 7.16b - Cost of Revenue TTM 4.57b) / Revenue TTM)
Gross Margin QoQ = 36.25% (prev 35.76%)
Tobins Q-Ratio = 2.90 (Enterprise Value 47.00b / Total Assets 16.18b)
Interest Expense / Debt = 0.82% (Interest Expense 22.5m / Debt 2.75b)
Taxrate = 17.09% (76.5m / 448.0m)
NOPAT = 1.53b (EBIT 1.85b * (1 - 17.09%))
Current Ratio = 1.16 (Total Current Assets 3.06b / Total Current Liabilities 2.65b)
Debt / Equity = 0.26 (Debt 2.75b / totalStockholderEquity, last quarter 10.53b)
Debt / EBITDA = 1.07 (Net Debt 2.31b / EBITDA 2.16b)
Debt / FCF = 1.40 (Net Debt 2.31b / FCF TTM 1.64b)
Total Stockholder Equity = 10.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.08% (Net Income 1.47b / Total Assets 16.18b)
RoE = 14.49% (Net Income TTM 1.47b / Total Stockholder Equity 10.14b)
RoCE = 15.99% (EBIT 1.85b / Capital Employed (Equity 10.14b + L.T.Debt 1.43b))
RoIC = 12.53% (NOPAT 1.53b / Invested Capital 12.24b)
WACC = 8.45% (E(44.69b)/V(47.44b) * Re(8.93%) + D(2.75b)/V(47.44b) * Rd(0.82%) * (1-Tc(0.17)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF Debug] Terminal Value 78.37% ; FCFE base≈1.66b ; Y1≈2.01b ; Y5≈3.31b
Fair Price DCF = 207.8 (DCF Value 47.84b / Shares Outstanding 230.2m; 5y FCF grow 22.85% → 3.0% )
EPS Correlation: 59.92 | EPS CAGR: 8.24% | SUE: 4.0 | # QB: 17
Revenue Correlation: 89.26 | Revenue CAGR: 5.68% | SUE: 2.21 | # QB: 2

Additional Sources for AME Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle